Lactibiane iki
Commercial- Indications
- Digestive health, Multiple sclerosis
Company intelligence / Profile preview
PiLeJe has over three decades of experience developing commercialized products in micronutrition, probiotics/microbiotics, phytotherapy, and medical nutrition. Its flagship probiotic range "Lactibiane" has been clinically studied for efficacy in IBS. The company collaborates with research organizations to validate its formulations but does not develop prescription drugs or biologics.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PiLeJe.